πŸ‡ΊπŸ‡Έ FDA
Patent

US 8277831

Drug-enhanced adhesion prevention

granted A61KA61K9/1647A61P

Quick answer

US patent 8277831 (Drug-enhanced adhesion prevention) held by Advanced Technologies and Regenerative Medicine, LLC expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Advanced Technologies and Regenerative Medicine, LLC
Grant date
Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K9/1647, A61P, A61P41/00